SHELBY GREGORY: Open Payments
NPI 1285366641 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 21 payments from 9 companies in 2025. Trend: 2023 $120 · 2024 $323 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $178 |
| Novo Nordisk Inc | 6 | $154 |
| ABBVIE INC. | 5 | $146 |
| BridgeBio Pharma, Inc. | 1 | $138 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| PFIZER INC. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: BOTOX, Attruby, Wegovy, ZEPBOUND, MOUNJARO, Ozempic, LEQVIO, VARIVAX.
Industry payments across NV — which companies pay providers there.
